180 related articles for article (PubMed ID: 21951066)
1. The oxysterol 27-hydroxycholesterol regulates α-synuclein and tyrosine hydroxylase expression levels in human neuroblastoma cells through modulation of liver X receptors and estrogen receptors--relevance to Parkinson's disease.
Marwarha G; Rhen T; Schommer T; Ghribi O
J Neurochem; 2011 Dec; 119(5):1119-36. PubMed ID: 21951066
[TBL] [Abstract][Full Text] [Related]
2. 27-Hydroxycholesterol Drives the Spread of α-Synuclein Pathology in Parkinson's Disease.
Dai L; Wang J; Zhang X; Yan M; Zhou L; Zhang G; Meng L; Chen L; Cao X; Zhang Z; Wang G; Zhang Z
Mov Disord; 2023 Nov; 38(11):2005-2018. PubMed ID: 37593929
[TBL] [Abstract][Full Text] [Related]
3. Modulation of TRPV1 and TRPA1 Channels Function by Sea Anemones' Peptides Enhances the Viability of SH-SY5Y Cell Model of Parkinson's Disease.
Kolesova YS; Stroylova YY; Maleeva EE; Moysenovich AM; Pozdyshev DV; Muronetz VI; Andreev YA
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203538
[TBL] [Abstract][Full Text] [Related]
4. Alpha-synucleinopathy reduces NMNAT3 protein levels and neurite formation that can be rescued by targeting the NAD+ pathway.
Parsons RB; Kocinaj A; Ruiz Pulido G; Prendergast SA; Parsons AE; Facey PD; Hirth F
Hum Mol Genet; 2022 Aug; 31(17):2918-2933. PubMed ID: 35397003
[TBL] [Abstract][Full Text] [Related]
5. The identification of cianidanol as a selective estrogen receptor beta agonist and evaluation of its neuroprotective effects on Parkinson's disease models.
Rymbai E; Sugumar D; Chakkittukandiyil A; Kothandan R; Selvaraj J; Selvaraj D
Life Sci; 2023 Nov; 333():122144. PubMed ID: 37797687
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of 24(S)-hydroxycholesterol esters responsible for the induction of neuronal cell death.
Shibuya K; Watanabe T; Urano Y; Takabe W; Noguchi N; Kitagishi H
Bioorg Med Chem; 2016 Jun; 24(11):2559-2566. PubMed ID: 27117262
[TBL] [Abstract][Full Text] [Related]
7. 27-Hydroxycholesterol propagates α-synuclein pathology in Parkinson disease.
Kiani L
Nat Rev Neurol; 2023 Oct; 19(10):573. PubMed ID: 37670140
[No Abstract] [Full Text] [Related]
8. Contribution of cholesterol and oxysterols to the pathophysiology of Parkinson's disease.
Doria M; Maugest L; Moreau T; Lizard G; Vejux A
Free Radic Biol Med; 2016 Dec; 101():393-400. PubMed ID: 27836779
[TBL] [Abstract][Full Text] [Related]
9. Isopentenyl diphosphate isomerase, a cholesterol synthesizing enzyme, is localized in Lewy bodies.
Nakamura K; Mori F; Tanji K; Miki Y; Yamada M; Kakita A; Takahashi H; Utsumi J; Sasaki H; Wakabayashi K
Neuropathology; 2015 Oct; 35(5):432-40. PubMed ID: 25950736
[TBL] [Abstract][Full Text] [Related]
10. Chaperone mediated autophagy to the rescue: A new-fangled target for the treatment of neurodegenerative diseases.
Xilouri M; Stefanis L
Mol Cell Neurosci; 2015 May; 66(Pt A):29-36. PubMed ID: 25724482
[TBL] [Abstract][Full Text] [Related]
11. Liver X receptor β protects dopaminergic neurons in a mouse model of Parkinson disease.
Dai YB; Tan XJ; Wu WF; Warner M; Gustafsson JÅ
Proc Natl Acad Sci U S A; 2012 Aug; 109(32):13112-7. PubMed ID: 22826221
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiological role of 27-hydroxycholesterol in human diseases.
Kim D; Lee KM; Lee C; Jo YS; Muradillaevna MS; Kim JH; Yoon JH; Song P
Adv Biol Regul; 2022 Jan; 83():100837. PubMed ID: 34774482
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of the estrogen receptor agonist estradiol on toxicity induced by enzymatically-derived or autoxidation-derived oxysterols in human ARPE-19 cells.
Dasari B; Prasanthi JR; Meiers C; Singh BB; Ghribi O
Curr Eye Res; 2013 Nov; 38(11):1159-71. PubMed ID: 23841471
[TBL] [Abstract][Full Text] [Related]
14. The Contribution of Type 2 Diabetes to Parkinson's Disease Aetiology.
Ribarič S
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673943
[TBL] [Abstract][Full Text] [Related]
15. Enzymatically Formed Oxysterols and Cell Death.
Urano Y; Noguchi N
Adv Exp Med Biol; 2024; 1440():193-211. PubMed ID: 38036881
[TBL] [Abstract][Full Text] [Related]
16. Impact of Oxysterols in Age-Related Disorders and Strategies to Alleviate Adverse Effects.
Ghosh S; Ghzaiel I; Vejux A; Meaney S; Nag S; Lizard G; Tripathi G; Naez F; Paul S
Adv Exp Med Biol; 2024; 1440():163-191. PubMed ID: 38036880
[TBL] [Abstract][Full Text] [Related]
17. Role of Brain Liver X Receptor in Parkinson's Disease: Hidden Treasure and Emerging Opportunities.
Alnaaim SA; Al-Kuraishy HM; Alexiou A; Papadakis M; Saad HM; Batiha GE
Mol Neurobiol; 2024 Jan; 61(1):341-357. PubMed ID: 37606719
[TBL] [Abstract][Full Text] [Related]
18. The potential role of cholesterol in Parkinson's disease neuropathology: perpetrator or victim.
Alrouji M; Al-Kuraishy HM; Al-Mahammadawy AAA; Al-Gareeb AI; Saad HM; Batiha GE
Neurol Sci; 2023 Nov; 44(11):3781-3794. PubMed ID: 37428278
[TBL] [Abstract][Full Text] [Related]
19. Lipid-lowering drug targets and Parkinson's disease: A sex-specific Mendelian randomization study.
Zhao Y; Gagliano Taliun SA
Front Neurol; 2022; 13():940118. PubMed ID: 36119674
[TBL] [Abstract][Full Text] [Related]
20. Genotypic-Phenotypic Analysis, Metabolic Profiling and Clinical Correlations in Parkinson's Disease Patients from Tamil Nadu Population, India.
Venkatesan D; Iyer M; S RW; Narayanasamy A; Kamalakannan S; Valsala Gopalakrishnan A; Vellingiri B
J Mol Neurosci; 2022 Aug; 72(8):1724-1737. PubMed ID: 35676593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
